Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Reduced shedding often precedes visible thickening
Published phase 2 research reported that the most common adverse events in retatrutide groups were gastrointestinal, dose-related, and mostly mild to moderate in severity
The global peptide therapeutics market has expanded substantially, driven by advances in synthesis technologies, improved understanding of peptide pharmacology, and successful clinical outcomes across various medical conditions
women's health (PCOS & Menopause) subscriptions $65/mo
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
